tirzepatide suicidal ideation not linked to increased risk for depression Compounded Tirzepatide Weight Loss Program

Between February 2019 and December 2023, 352 reports of adverse events from compounded GLP-1 drugs rolled into the FDA, most submitted by patients and health care providers

How does TrimRx support individuals on their weight loss journey

It should not be taken alongside other GLP-1 receptor agonists

In such cases, combination therapy with basal insulin or other agents may be necessary, or alternative treatment approaches might be more appropriate

Please make sure you call your pharmacy benefit manager (PBM) as they will handle the prior authorization for your prescription and not your medical insurance network

But if your progress has slowed after spending time on the 2.4 mg dose, your provider may consider whether the newer 7.2 mg option could help support additional weight loss